Biocartis Group NV
F:8XB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biocartis Group NV
F:8XB
|
BE |
|
Oponeo.pl SA
F:79I
|
PL |
|
SVB Financial Group
F:SV4
|
US |
|
T
|
Tosei Corp
OTC:TOETF
|
JP |
|
Circio Holding ASA
F:TA50
|
NO |
|
F
|
Future Corp
XMUN:FSX
|
JP |
|
1
|
1CM Inc
F:IQ70
|
CA |
|
M
|
MPC Muenchmeyer Petersen Capital AG
XBER:MPCK
|
DE |
|
A
|
Anhui Expressway Co Ltd
F:HU7
|
CN |
|
A
|
Accsys Technologies PLC
F:1D8
|
UK |
|
R
|
RTW Venture Fund Ltd
OTC:RTWFF
|
GG |
|
H
|
Hirose Electric Co Ltd
F:HRO
|
JP |
|
Voltabox AG
F:VBX
|
DE |
|
Monde Nissin Corp
OTC:MNDDF
|
PH |
|
B
|
Bank Pan Indonesia Tbk PT
XMUN:PTQ
|
ID |
|
Aozora Bank Ltd
F:AON0
|
JP |
|
G
|
Gold Mountain Mining Corp
OTC:GMTNF
|
CA |
|
Appier Group Inc
OTC:APPIF
|
JP |
|
A
|
Anhui Expressway Co Ltd
OTC:AUHEF
|
CN |
|
D
|
Dmg Blockchain Solutions Inc
F:6AX
|
CA |
|
M
|
Mitsubishi Paper Mills Ltd
F:MPX
|
JP |
|
Brave Bison Group PLC
F:RT70
|
UK |
|
Adcore Inc
F:ADQ
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8XB's stock price target?
Not Available
8XB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biocartis Group NV?
Projected CAGR
21%
Over the last 9 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 21%.